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Electrospray ionization (ESI) quadrupole ion-trap tandem mass spectrometry (MS/MS) was
utilized to characterize a class of complex oligosaccharide antibiotics (everninomicins) that
include SCH 27899, everninomicin-D, amino everninomicin (SCH 27900), and SCH 49088
(containing a hydroxylamino-ether sugar). The addition of sodium chloride (1 g/mL)
facilitates the formation of abundant metal complex ions, and this was used because
protonation does not readily occur for most of these compounds. The multiple-stage mass
analysis (MSn) of the sodiated species provides an important series of fragment ions that are
specific for sugar sequence and for some sugar-ring opening. These data suggest a general
charge-remote fragmentation pattern with the sodium cation residing in a specific, central
location of the sugar chain and fragmentation occurring to trim the end of the molecule. For
protonated everninomicin (SCH 27900), however, the proton appears to be mobile during the
collisional activation process, opening different fragmentation pathways depending on the
proton location. The use of water and acetonitrile with 0.1% acetic acid as the solvent in ESI-MS
promotes rapid hydrolysis of the central ortho ester, resulting in the formation of abundant
sodiated products that are hydrated. These product ions of the hydrated molecules are likely
formed by the same charge-remote fragmentation processes as those that occur for the
unhydrolyzed precursor. (J Am Soc Mass Spectrom 2002, 13, 1313–1321) © 2002 American
Society for Mass Spectrometry
Everninomicins are an important group of oligo-saccharide antibiotics produced by Micromonos-pora carbonacea [1]; these antibiotics are highly
active against gram-positive bacteria including methi-
cillin-resistant Staphylococcus aureus and vancomycin-
resistant enterococci [2–4]. This class of antibiotics has a
complex, eight-sugar backbone with two ortho ester
functionalities. Other unusual structural features in-
clude a nitrosugar, a completely substituted aromatic
ester containing two chlorines, and a methylene dioxy
group.
The early structural characterization work on this
class of compounds made use of a Ganguly-Sarre
chemical degradation procedure [5–7]. In subsequent
studies by the Schering-Plough group, fast-atom bom-
bardment (FAB) mass spectrometry (MS) was used to
characterize everninomicins [8–14]. The limitations of
FAB-MS on sector instruments for these compounds
include relatively poor sensitivity and limited tandem
mass spectrometry (MS/MS) capability for detailed
fragmentation studies as compared to electrospray ion-
ization (ESI) with contemporary instruments.
Recently, we employed high-resolution ESI liquid
chromatography (LC)/MS to identify several impurities
and degradation products of SCH 27899, one of the
everninomicin components isolated from a fermenta-
tion broth [15]. The data clearly demonstrated the
feasibility of using ESI-MS to analyze samples contain-
ing everninomicins.
Coupling ESI [16] with a quadrupole ion-trap mass
spectrometer provides the ability to perform MSn ex-
periments and obtain structural information [17–24].
We wish to take advantage of the MSn capability of the
ion trap because it appears to be invaluable for the
structural elucidation of complex molecules.
In the research reported in this article, we explore the
use of ESI-MSn in a quadrupole ion-trap mass spec-
trometer for structural characterization of several ever-
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ninomicins including SCH 27899 (Scheme 1, A), everni-
nomicin-D (Scheme 3, C) [2], amino everninomicin
(SCH 27900, Scheme 4, D) [25] and SCH 49088 contain-
ing a hydroxylamino-ether sugar (Scheme 6, E) [26]. The
objective is to interpret the fragmentation patterns of
these compounds, seen by multiple-stage MS/MS ex-
periments (ESI-MSn), and to determine whether the
fragmentations are structurally useful. The prospects
for utilizing charge-remote fragmentation [27–30] for
this class of compounds is a secondary goal.
Experimental
SCH 27899, everninomicin-D, amino everninomicin,
and SCH 49088 were isolated from a fermentation broth
at the Schering-Plough Research Institute, Kenilworth,
NJ. The isolation procedures were described previously
[2, 11, 25, 26]. The samples were dissolved in HPLC-
grade acetonitrile (Fisher Scientific, Fair Lawn, NJ). A
small amount of NaCl (1 g/mL) was added to the
sample solution prior to the MS analysis to facilitate the
formation of abundant complex ions containing sodium
ions.
All experiments were carried out on a Finnigan
LCQ-deca (San Jose, CA) ion-trap mass spectrometer
equipped with an ESI source. The sample solution (5
pmol/L) was introduced into the ESI source by direct
infusion at a flow rate of 5 L/min. The ESI needle was
held at 4.1 kV, and a 1.4  105 Pa nitrogen sheath gas
was used to stabilize the spray. The heated capillary
was set at 250 °C. The helium was introduced into the
ion-trap to improve the trapping efficiency and also to
serve as the collision gas for CID. The operational
pressure after introducing helium was at 1.9  103 Pa.
The instrument was operated in the positive-ion
mode with the conversion dynode voltage at 15 kV. A
typical set of experimental parameters includes a max-
imum ion injection time of 250 ms and three “mi-
croscans” per analytical scan. In the MSn experiments,
standard resonance excitation was employed. The qz
value was set at 0.25, which is typical, and the activation
time was 30 ms. The isolation width was typically at 1.5
Da/charge. The activation amplitude, represented as a
percentage of full activation voltage, was optimized
(5–100%) to facilitate fragmentation of precursor ions.
Results and Discussion
SCH 27899
SCH 27899 (Ziracin, Scheme 1, A) is a leading drug
candidate in the everninomicin family of antibiotics to
treat drug-resistant microorganisms. The positive-ion
ESI mass spectrum of SCH 27899 obtained in acetoni-
trile by direct infusion (Figure 1a) shows a base peak
representing the sodiated molecule at m/z 1652. The
insert clearly indicates its isotopic pattern, consistent
with the presence of two chlorine atoms in the mole-
cule. To observe abundant sodiated molecules required
the addition of NaCl. The two ions at m/z 1670 and 1688
represented molecular ions of hydrated products of
SCH 27899, [MH2ONa]
 and [M 2H2ONa]
,
respectively. The structure of the ion at m/z 1670 repre-
senting the product for addition of one molecule of
water (Scheme 2, B) is consistent with our previous
report that SCH 27899 can undergo sequential hydro-
lysis of ortho ester functionalities [8, 11]. The initial
hydrolysis occurs at the central ortho ester group (be-
tween ring B and D, Scheme 1, A). It is likely that the
presence of water in the sample and the instrument
contributes to the hydrolysis process. When SCH 27899
was dissolved in a mixture of water and acetonitrile
with 0.1% acetic acid, its ESI mass spectrum (Figure 1b)
became quite different from that in Figure 1a. Notice-
ably, the base peak now represents the water-addition
product ion [M  H2O  Na]
, whereas the relative
abundance of sodiated SCH 27899 [M  Na] is much
lower (7% relative abundance in the spectrum, m/z
1652). It appears that the solvent (H2O/CH3CN) favors
Scheme 1. Proposed key fragmentation of sodiated SCH 27899
molecules to give positive ions. Structure of SCH 27899 is shown
in A.
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the hydrolysis process, resulting in higher abundant
hydrated product ions. Clearly, the appearance of ESI
mass spectra of SCH 27899 is influenced by the sample
preparation, and the formation of hydrated product
ions is a disadvantage in the structural determination of
everninomicins by ESI-MS.
The generation of abundant molecular ions with
limited or no fragments is consistent with the “soft”
nature of the ESI process. This is in contrast to FAB
mass spectra of SCH 27899 and other everninomicins,
where both abundant sodiated molecules and some
structurally informative fragment ions were observed
[8–11, 13, 14]. Nevertheless, a reliable way of obtaining
structural information is to perform tandem MS exper-
iments on specific ions of interest.
The product-ion spectra of positive ions from sodi-
ated SCH 27899 molecule [M  Na] at m/z 1652 are
taken upon multiple collisions in the ion-trap (Figure 2),
and they clearly show one fragmentation pathway: m/z
1652 3 m/z 1502 3 m/z 1455 3 m/z 807 3 m/z 665 3.
The loss of ring 2 as a neutral from the sodiated SCH
27899 molecule (m/z 1652) leads to the ion at m/z 1502
(Scheme 1, 1a). A subsequent loss of HNO2 from ring K
results in the formation of an abundant ion at m/z 1455
(1b), which, when further activated by collisions, pro-
duces a number of sodiated ions with that of m/z 807
(1e) being the most abundant. This ion possibly repre-
sents a penta-saccharide (ring D through ring I), gener-
Figure 1. (a) The positive-ion ESI mass spectrum of SCH 27899
obtained in acetonitrile. The insert shows the isotopic pattern of
the sodiated SCH 27899 molecule. (b) The positive-ion ESI mass
spectrum of SCH 27899 obtained by using a mixture of water,
acetonitrile, and 0.1% acetic acid.
Scheme 2. Proposed key fragmentation of sodiated water-addi-
tion product of SCH 27899 to give positive ions. Structure of
water-addition product of SCH 27899 is shown in B.
Figure 2. (a) The product-ion mass spectrum of positive ions of
m/z 1652 ([M  Na]) for SCH 27899. (b) The product-ion mass
spectrum (MS3) of positive ions at m/z 1502 derived from ions at
m/z 1652. (c) The product-ion mass spectrum (MS4) of positive ions
of m/z 1455 derived from ions of m/z 1502. (d) The product-ion
mass spectrum (MS5) of positive ions of m/z 807 derived from ions
of m/z 1455. (e) The product-ion mass spectrum (MS6) of positive
ions of m/z 665 derived from ions of m/z 807.
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ated by the cleavage of the central ortho ester function
(ring C). The further fragmentation of the m/z 807 ion
(Figure 2d) generates a product ion of m/z 665 (1h),
which yields ions at m/z 505 (1i), 487 (1j), and 449 (1k).
These proposed fragmentation pathways suggest that
the sodium cation resides between ring F and G. It is
important to note that this location is relatively rich in
oxygen atoms, consistent with the oxyphilic nature of
the alkali metal ions. A similar trimming by CID was
found in studies of the central calcium-binding site in
peptides [31]. The ends of the molecule were cut away
to reveal the site of metal-ion binding.
As can be seen in Figure 2 and Scheme 1, a simple
cleavage of sugar ether linkages can also produce a
series of other ions at m/z 1315, 1049, 935, 825 (1d), and
647 (1g) that define the sugar sequences in the molecule.
The loss of ring K from ion of m/z 1455 (1b) with
addition of a proton can produce the ion of m/z 1315.
The successive losses of the substituted benzenecarboxy
group (ring 1) and ring K bearing the oxygen from m/z
1502 (1a) could produce the fragment ion of m/z 1049.
The ion at m/z 935 possibly represents sugar ring B
through I, which is formed by the loss of
(1™(C¢O)™O™A™O™K) moiety from 1a. In addition, the
opening of sugar rings leads to several structurally
characteristic fragment ions. For example, the ions at
m/z 723 (1f) and 693 (opening of ring D from 1e) are
results of possible bond cleavages in sugar ring D. The
ion of m/z 1343 is likely to be formed by the loss of
HNO2 and subsequent opening of ring K to produce a
sodiated O-formyl ion (H™(C¢O)™O™A) from 1a.
Similar MSn analysis was also performed on water-
addition product of SCH 27899, [M  H2O  Na]
 at
m/z 1670 (data not shown). Its fragmentation, illustrated
in Scheme 2, yields two key product ions that define the
hydrolysis site between ring B and C: Ions of m/z 953
(2c) and 807 (1e). The corresponding ions for sodiated
SCH 27899 are m/z 935 and 807, respectively. The shift
of the m/z 935 ion to m/z 953 (2c) indicates that one
molecule of water added along the right portion of the
molecule starting from ring B. Correspondingly, the
lack of shift of the m/z 807 ion suggests that the addition
site is between ring B and C. The sodium cation in the
water-addition product of SCH 27899 appears to bind
between rings F and G, as revealed by the fragmenta-
tion studies, viz. the observation of ions at m/z 487 (1j)
and 449 (1k). As in the case of sodiated SCH 27899,
sodiated hydrated molecules dissociated to yield sugar
sequence-specific product ions [i.e., ions of m/z 1520
(2a), 1333 (loss of ring K from 2a), 1315 (loss of H2O
from m/z 1333), and 1067 (loss of 1™(C¢O)™O moiety
from m/z 1315)] along with some ring-opened product
ions [i.e., m/z 999 (representing sugar ring D through I
and part of sugar ring A) and 449 (1k)].
The sodium cation does not appear to be mobile
under the conditions of low-energy collisional activa-
tion, a situation that contrasts with the low-energy
fragmentations of protonated peptides [32]. With a
stable, “fixed” site for the charged sodium for these
everninomicins, the fragmentations are likely to be
charge-remote [27–30, 33–35]. The results from the
ion-trap experiments are distinctively different from the
previous FAB-MS data obtained by using sector instru-
ments [8–10, 13, 14]; under high-energy collisions, the
sodium cation appears to be mobile when attached to
everninomicins, resulting in mass spectra different from
those we see here. It is notable that low-energy colli-
sions in an ion-trap mass spectrometer are a richer
source of informative fragmentation for this class of
compounds.
Everninomicin-D
Everninomicin-D is a main component of the isolated
fermentation broth [2]. As for SCH 27899, everninomi-
cin-D gave an abundant sodiated molecule [M  Na]
at m/z 1558 upon ESI (data not shown). In addition, two
ions of m/z 1576 and 1594 result from addition of one
and two molecules of water: [M  H2O  Na]
 and
[M  2H2O  Na]
, respectively. The presence of
adventitious traces of water in the sample contributed
to the hydration process because no aqueous solvent
was used during the experiment.
A four-stage mass analysis of the sodiated everni-
nomicin-D [MNa] at m/z 1558 illustrates a dominant
fragmentation pathway: m/z 1558 3 m/z 1399 3 m/z
8633m/z 7373 (Figure 3). The loss of HNO2 from ring
K results in a product ion of m/z 1511 (3a) and a further
loss of 112 Da, likely to be CH3™CH¢C(OCH3)™C
(CH3)¢CH2, from the fragmentation of ring K leads to
the ion of m/z 1399 (3b; Figure 3a). The product ion of
m/z 1399 produces an abundant m/z 863 ion (3c), which
defines the right portion of the molecule from the
central ortho ester group (ring C) (Figure 3b). Further
Figure 3. (a) The product-ion mass spectrum of positive ions of
m/z 1558 ([M  Na]) for everninomicin-D. (b) The product-ion
mass spectrum (MS3) of positive ions of m/z 1399 derived from
ions of m/z 1558. (c) The product-ion mass spectrum (MS4) of
positive ions of m/z 863 derived from ions of m/z 1399. (d) The
product-ion mass spectrum (MS5) of positive ions of m/z 737
derived from ions of m/z 863.
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fragmentation of m/z 863 yields product ions of m/z 737
(3e), 645 (3d), and 499 (3f) (Figure 3c; Scheme 3).
Upon further activation, the ion at m/z 737 generates
a number of higher generation product ions, including
those of m/z 663 (3g), 577 (3h), 503 (loss of rings H, I, J
from 3e), 391 (opening of rings E, H and loss of rings I
and J from 3e), and 373 (3j) (Figure 3d; Scheme 3). This
fragmentation pathway clearly indicates that the so-
dium cation in the complex ion is located between ring
F and G, as discussed previously for SCH 27899. As in
the case of SCH 27899, low-energy multiple collisions of
sodiated everninomicin-D also generate both sugar
sequence-specific ions (i.e., of m/z 1105, representing
sugar ring A through I, Scheme 3), 991 (loss of ring A
from m/z 1105), 881 (loss of ring B from m/z 991), and
ions formed by sugar-ring opening [i.e., of m/z 1037
(loss of rings 1, K, and part of ring A from sodiated
everninomicin-D molecule), 951 (loss of rings 1, A, and
part of ring B from 3b), 765 (opening of ring D from 3c),
and 663 (3g)].
The incorporation of a sodium cation in the complex
molecule causes the subsequent fragmentation to be
rich in information. Once again, the “fixed” sodium site
in the metal complex ion opens the door to charge-
remote processes.
Amino Everninomicin
Amino everninomicin is a minor component isolated
from the fermentation broth [25]. Compared with SCH
27899, SCH 27900 has a primary amine group instead of
the nitro function on sugar K (Scheme 4, D). This
change in a functional group leads to significant
changes in the appearance of the ESI mass spectrum
(Figure 4). The base peak in the spectrum corresponds
to the protonated molecule [M  H] at m/z 1600,
whereas the sodiated molecule [M  Na] at m/z 1622
forms at lower abundance. This contrasts with the ESI
mass spectra of SCH 27899 and everninomicin-D, for
which the dominant ions are sodiated molecules.
The product-ion spectrum of the protonated mole-
cule [MH] at m/z 1600 (Figure 5a) shows a base peak
at m/z 666 (4c), which defines the left portion of the
molecule starting at the central ortho ester group (ring
C). Another fragment, that of m/z 935 (4b), provides the
information on the right portion of the molecule start-
ing at the central ortho ester group. Further fragmenta-
tion of the ion at m/z 666 yields some product ions that
are specific for the sugar sequence, such as those of m/z
Scheme 3. Proposed key fragmentation of sodiated everninomi-
cin-D molecules to give positive ions. Structure of everninomi-
cin-D is shown in C.
Scheme 4. Proposed key fragmentation of protonated amino
everninomicin molecules to give positive ions. Structure of amino
everninomicin is shown in D.
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520 (4f), 345 (4g), and 233 (ring 1) (Figure 5b; Scheme 4).
The product-ion spectrum of m/z 935 shows a series of
sugar sequence-specific ions of m/z 793 (4e), 633 (4h),
443 (4d), and 293 (loss of ring 2 from 4d) (Figure 5c). The
fragmentation patterns, illustrated in Scheme 4, suggest
that the proton in the protonated molecule appears to
be mobile during the activation (similar to that for the
fragmentation of peptides [32]) and results in the for-
mation of a complex array of fragment ions that are
specific for sugar sequence.
When the sodium cation was incorporated into the
molecule, the complex ion fragmented to generate a
dominant ion at m/z 1472 (5a) as a result of loss of ring
2 (Figure 6a). Its further fragmentation produces a
number of product ions that are specific for sugar
sequence at m/z 1315 (loss of ring K from 5a), 1065 (loss
of substituted carboxy ring 1 from m/z 1315), 825 (1d),
807 (1e), 665 (1h), and 487 (1j) (Figure 6b). Some
fragment ions formed via ring opening are of m/z 895
(1c) and 723 (1f). The product-ion at m/z 665, when
submitted to further collisional activation, gives several
sub-product ions at m/z 505 (1i), 487, and 449 (1k)
(Figure 6c), as summarized in Scheme 5.
As for the other sodiated everninomicin molecules
(SCH 27899, everninomicin-D), the sodium cation is
likely to be located between rings F and G, binding to
ring F and G through the three oxygen atoms. The
observed fragmentations of the sodiated molecule for
this everninomicin are also likely charge-remote. For
this class of analytes, the sodiated molecules generate
both sequence-specific fragment ions and ring-opening
fragment ions, whereas the protonated molecules gen-
erally give sequence-specific fragment ions.
Figure 4. The positive-ion ESI mass spectrum, obtained in ace-
tonitrile, of amino everninomicin.
Figure 5. (a) The product-ion mass spectrum of positive ions of
m/z 1600 ([MH]) for amino everninomicin. (b) The product-ion
mass spectrum (MS3) of positive ions of m/z 666 derived from ions
of m/z 1600. (c) The product-ion mass spectrum (MS3) of positive
ions of m/z 935 derived from ions of m/z 1600.
Figure 6. (a) The product-ion mass spectrum of positive ions of
m/z 1622 ([M  Na]) for amino everninomicin. (b) The product-
ion mass spectrum (MS3) of positive ions at m/z 1472 derived from
ions at m/z 1622. (c) The product-ion mass spectrum (MS4) of
positive ions at m/z 665 derived from ions of m/z 1472.
Scheme 5. Proposed key fragmentation of sodiated amino ever-
ninomicin molecules to give positive ions.
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SCH 49088
SCH 49088 is a newly isolated everninomicin antibiotic
containing a unique O-alkylated hydroxylamine substi-
tuted sugar subunit [26]. The positive-ion ESI mass
spectrum shows a base peak at m/z 1910, corresponding
to the sodiated molecule [M  Na] (data not shown).
Additionally, an abundant molecular ion of the hy-
drated material, [MH2ONa]
 at m/z 1928 provides
evidence for some hydrolysis.
The three-stage mass spectrometric analysis of the
sodiated molecule [M  Na] at m/z 1910 (Figure 7a)
shows that several product ions arise in the high mass
region, including those of m/z 1855, 1841, 1823, and
1782. The losses of C4H7 (55 u) and C5H9 (69 u) from the
side chain of the O-alkylated hydroxylamine subunit
likely produce ions of m/z 1855 and 1841, respectively.
A further loss of water and C2H3O2 (59 u) from the ion
of m/z 1841 leads to those of m/z 1823 and 1782,
respectively. Other fragment ions related to the loss of
side chain of O-alkylated hydroxylamine subunit of the
sodiated molecule include those of m/z 1637 and 1576.
The loss of both the side chain of O-alkylated hydrox-
ylamine subunit and ring K leads to an ion at m/z 1465
(6b). Structural information on the side chain of the
hydroxylamine subunit is very much evident in the
fragmentation of the sodiated molecules. A ready loss
of a species containing ring 2 from the complex ion
generates the ion of m/z 1760 (6a). Its further dissocia-
tion yields the ions of m/z 1488 (loss of side chain of
O-alkylated hydroxylamine subunit) and 1315 (6c). Fur-
ther activation of the m/z 1315 ion produces a number of
structurally informative product ions (Figure 7b), in-
cluding sugar sequence-specific ions [i.e., of m/z 953
(6d), 825 (1d), 665 (1h), 487 (1j)], and sugar ring-opening
ions [i.e., of m/z 1023 (loss of ring 1 and part of ring A
from 6c), 895 (1c), 851 (loss of ring A and part of ring B
from m/z 1023), and 807 (1e)].
The fragmentation of the m/z 665 ion establishes the
location of sodium cation to be between rings F and G
(Figure 7c; Scheme 6). The observed fragmentation is
again best explained as charge-remote for this sodiated
molecule.
Conclusions
Using ESI-MS and ESI-MSn, we characterized several
complex oligosaccharides (everninomicins) in a quad-
rupole ion-trap. The choice of solvent in sample prep-
aration determines the appearance of the ESI mass
spectra. The sodiated water-addition product of SCH
27899 is dominant when SCH 27899 is prepared in a
mixture of water and acetonitrile with 0.1% acetic acid.
Abundant sodiated molecules of everninomicin-D and
SCH 49088 form under ESI conditions in the presence of
acetonitrile, whereas the protonated molecule is the
major ion that forms for amino everninomicin.
The ESI-MSn studies have provided detailed struc-
tural information on these compounds. In general, the
sodiated molecules appear to undergo charge-remote
fragmentations with the sodium cation “locked” be-
tween sugar rings F and G. Fragment ions that are likely
specific for the sugar sequence and for ring-opening are
formed. On the other hand, protonated molecules for
Figure 7. (a) The product-ion mass spectrum of positive ions of
m/z 1910 ([M  Na]) for SCH 49088. (b) The product-ion mass
spectrum (MS3) of positive ions at m/z 1315 derived from ions of
m/z 1910. (c) The product-ion mass spectrum (MS4) of positive ions
at m/z 665 derived from ions of m/z 1315.
Scheme 6. Proposed key fragmentation of sodiated SCH 49088
molecules. Structure of SCH 49088 is shown in E.
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the amino everninomicin fragment to yield more com-
plicated fragmentation patterns.
We demonstrated that the detailed fragmentation
patterns obtained from ESI-MSn studies are valuable for
structural elucidation of other related everninomicins.
Several characteristic fragment ions are observed to be
associated with changes on certain functional groups in
the everninomicins. For example, a loss of ring 2 is a
common process when the ring 2 is attached to the
sugar ring I. A loss of HNO2 from the various molecular
ions indicates the presence of a nitro group. The recent
development of successful total synthesis of SCH 27899
[36–38] and the preparation of semi-synthetic ana-
logues for biological investigations through solution
and solid-phase combinatorial chemistry [39] under-
score the need for characterizing this class of com-
pounds. ESI-MSn should provide an effective means to
meet this need for these compounds and their modified
analogs.
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